Cargando…
Targeting Toll‐like receptor‐4 to tackle preterm birth and fetal inflammatory injury
Every year, 15 million pregnancies end prematurely, resulting in more than 1 million infant deaths and long‐term health consequences for many children. The physiological processes of labour and birth involve essential roles for immune cells and pro‐inflammatory cytokines in gestational tissues. Ther...
Autores principales: | Robertson, Sarah A, Hutchinson, Mark R, Rice, Kenner C, Chin, Peck‐Yin, Moldenhauer, Lachlan M, Stark, Michael J, Olson, David M, Keelan, Jeffrey A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156293/ https://www.ncbi.nlm.nih.gov/pubmed/32313651 http://dx.doi.org/10.1002/cti2.1121 |
Ejemplares similares
-
Novel Toll-like receptor-4 antagonist (+)-naloxone protects mice from inflammation-induced preterm birth
por: Chin, Peck Yin, et al.
Publicado: (2016) -
Toll-like receptor-4 null mutation causes fetal loss and fetal growth restriction associated with impaired maternal immune tolerance in mice
por: Chan, Hon Y., et al.
Publicado: (2021) -
Macrophages exert homeostatic actions in pregnancy to protect against preterm birth and fetal inflammatory injury
por: Gomez-Lopez, Nardhy, et al.
Publicado: (2021) -
Editorial: Advances in the Prevention and Treatment of Inflammation-Associated Preterm Birth
por: Keelan, Jeffrey A., et al.
Publicado: (2016) -
Recent advances in the prevention of preterm birth
por: Keelan, Jeff A, et al.
Publicado: (2017)